H.C. Wainwright lifted its price target on shares of Cingulate (NASDAQ: CING) to $20.00, a significant increase from the previous target of $8.00. The firm has maintained a Buy rating on the stock, ...

Pivotal Research raised the price target for Meta Platforms, Inc. META from $800 to $875. Pivotal Research analyst Jeffrey ...

H.C. Wainwright raised the firm’s price target on Cingulate (CING) to $20 from $8 and keeps a Buy rating on the shares to reflect the recent ...

In this experiment, we pit a neuroscientist’s research against the real world to see if he can identify a person’s political ...

The study observed poor attention span and disturbed sleep among people with addiction to scrolling short videos.

Certain melodies promote brain development in premature infants. For several years, a team of scientists have observed this ...

In premature babies, music strengthens connections in certain areas of the brain, according to a years-long study by the University Hospitals of Geneva (HUG).

In uncertain situations where information is lacking, individuals often find themselves imitating the choices of others. For ...

A study reveals cannabis use may exacerbate synaptic deficits in young adults at risk for psychosis, particularly during critical brain development periods.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

KANSAS CITY, Kan., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform ...

As of December 23, 2024, the average one-year price target for Cingulate is $61.46/share. The forecasts range from a low of $8.08 to a high of $100.80. The average price target represents an ...